LARS anticorps (N-Term)
Aperçu rapide pour LARS anticorps (N-Term) (ABIN2297311)
Antigène
Voir toutes LARS AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 183-213, N-Term
-
Réactivité croisée
- Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Mo
-
Attributs du produit
- LARS, NT (LARS, KIAA1352, Leucine-tRNA ligase, cytoplasmic, Leucyl-tRNA synthetase)
-
Purification
- Purified by saturated ammonium sulfate precipitation followed by dialysis against PBS.
-
Immunogène
- LARS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 183-213 amino acids from the N-terminal region of human LARS.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LARS (Leucyl-tRNA Synthetase (LARS))
-
Autre désignation
- LARS
-
NCBI Accession
- NP_064502
-
UniProt
- Q9P2J5
-
Pathways
- EGFR Signaling Pathway
Antigène
-